Matinas BioPharma Holdings (MTNB) Accounts Payables (2013 - 2026)
Matinas BioPharma Holdings (MTNB) reported Accounts Payables of $845,000 for Q2 2026, up 406.0% from $167,000 a year earlier and up 18.7% from the prior quarter.
Powered by 
Analysis
Matinas BioPharma Holdings (MTNB) Accounts Payables (2013 - 2026) Analysis & Trends
At the end of FY2025, Matinas BioPharma Holdings posted Accounts Payables of $315,000, up 231.6% from FY2024.
- Accounts Payables has a five-year compound annual growth rate of -2.1% (FY2020 to FY2025).
- By year, Accounts Payables came in at $95,000 in FY2024 (-81.5%), $514,000 in FY2023 (-16.8%), $618,000 in FY2022 (-34.0%) and $937,000 in FY2021 (+167.8%).
- The Q2 2026 figure ranks as the highest quarterly Accounts Payables since Q3 2023.
- Year over year, Accounts Payables has now increased in each of the last three quarters, with growth averaging 60.1% over the last eight quarters.
- The high point for year-over-year Accounts Payables in five years was Q2 2026 (growth of 406.0%); the low point was Q2 2024 (a decline of 82.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $712,000 (Q1 2026), $315,000 (Q4 2025) and $80,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 9.22 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 3.83 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.58 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Matinas BioPharma Holdings | 18.13 Mn | 5.54 Mn | - | 845,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 845,000.00 |
| Mar 31, 2026 | 712,000.00 |
| Dec 31, 2025 | 315,000.00 |
| Sep 30, 2025 | 80,000.00 |
| Jun 30, 2025 | 167,000.00 |
| Mar 31, 2025 | 282,000.00 |
| Dec 31, 2024 | 95,000.00 |
| Sep 30, 2024 | 349,000.00 |
| Jun 30, 2024 | 238,000.00 |
| Mar 31, 2024 | 473,000.00 |
| Dec 31, 2023 | 514,000.00 |
| Sep 30, 2023 | 1.76 Mn |
| Jun 30, 2023 | 1.37 Mn |
| Mar 31, 2023 | 516,000.00 |
| Dec 31, 2022 | 618,000.00 |
| Sep 30, 2022 | 656,717.00 |
| Jun 30, 2022 | 497,151.00 |
| Mar 31, 2022 | 1.35 Mn |
| Dec 31, 2021 | 937,000.00 |
| Sep 30, 2021 | 661,998.00 |
API Access
Matinas BioPharma Holdings Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=MTNB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "MTNB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=MTNB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();